Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome

Johnson BD , Shaw LJ , Buchthal SD et al. Prognosis in women with myocardial ischaemia in the absence of obstructive coronary disease. Circulation 2004; 109: 2993—2999.

Hughes GR Thrombosis, abortion, cerebral disease and the lupus anticoagulant . BMJ 1983; 287: 1088—1089.

Khamashta MA , Cervera R. , Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541—1544.

Roman MJ , Salmon JE , Sobel R. et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid syndrome. Am J Cardiol 2001; 87: 663—666.

Cervera R. Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 2004; 114: 501—507.

Tenedios F. , Erkan D. , Lockshin MD Cardiac involvement in the antiphospholipid syndrome. Lupus 2005; 14: 691—696.

Kaplan SD , Chartash EK , Pizzarello RA , Furie RS Cardiac manifestations of antiphospholipid syndrome. Am Heart J 1992; 124: 1331—1338.

Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998; 7: S132—S134.

Hamsten A. , Norberg R. , Bjorkholm M. et al. Antibodies to cardiolipin in young survivors of myocardial infarctions: an association with recurrent cardiovascular events. Lancet 1986; 1: 113—116.

Nair S. , Khamashta MA , Hughes GRV. Syndrome X and Hughes syndrome. Lupus 2002 ; 11: 332.

Lagana B. , Baratta L. , Tubani L. , Golluscio V. , Delfino M. , Rossi Fanelli F. Myocardial infarction with normal coronary arteries in a patient with primary antiphospholipid syndrome. Case report and literature review. Angiology 2001; 52: 785—788.

Rangel A. , Lavalle C. , Chavez E. et al. Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis . Angiology 1999; 50: 249—253.

Thorp JM Jr , Chescheir NC , Fann B. Postpartum myocardial infarction in a patient with antiphospholipid syndrome. Am J Perinatol 1994; 11: 1—3.

Davies JO , Hunt BJ Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract 2007; 61: 379—384.

Zavaleta EN , Vargas-Barron J. , Colmenares-Gavis T. et al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 1999; 137: 973—978.

Zavaleta NE , Montes RM , Soto ME , Vanzzni NA , Amigo MC Primary antiphospholipid syndrome: a 5 year transesophageal echocardiographic followup study. J Rheumatol 2004; 31: 2329—2330.

Tanaseanu C. , Moldoveanu E. , Tanaseanu S. et al. Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction — distinct clinical subset. Rom J Intern Med 2004; 42: 545—556.

Soares-Costa JT , Soares Costa Teresa JJ. Cardiac Syndrome X. Rev Port Cardiol 2006; 25: 933—942.

Johnson BD , Shaw LJ , Pepine CJ et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006; 27: 1408—1415.

Gimbel Moral LF , de Miguel SC , Mugaraza HMD , Alonso SA , Castillo AP , Lopez RA Microvascular angina (Syndrome X): presentation of 4 cases. Aten Primaria 1995; 16: 356—358.

Letac B. , Berland J. , Cribier A. , Cazor JL , Hecketsweiler B. Angina pectoris with normal coronary arteries: clinical hemodynamic and metabolic study. Arch Mal Couer Vaiss 1983; 76: 211—222.

Panting JR , Gatehouse PD , Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948—1953.

Johnson DB , Shaw LJ , Buchtal SD et al. Prognosis in women with myocardial ischaemia in the absence of obstructive coronary disease. Circulation 2004; 109: 2993—2999.

Kaski JC Cardiac syndrome X in women: the role of oestrogen deficiency. Heart 2006; 92: iii5—iii9.

DeSilva PC , Sangle SR , Hughes GRV , D'Cruz DP Myocardial infarction despite normal coronary arteries (`Syndrome X') in patients with the antiphospholipid (Hughes) syndrome: a case series . Arthritis Rheum 2006; 54: S557 (abstract no.: 1344).

Kaski JC , Perez Fernandez R. Microvascular angina and syndrome X. Rev Esp Cardiol 2002; 55: 10—16.

Kaski JC , Elliot PM , Salomone O. et al. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620—624.

Michelakakis NA , Petropoulou EN , Lazarous GA et al. Comparison of Endothelin-1 levels at rest and during exercise between patients with cardiac syndrome x and healthy people. Acta Cardiol 1998; 53: 3—6.

Atsumi T. , Khamashta MA , Haworth RS et al. Arterial disease and thrombosis in the antiphospholipid syndrome, a pathogenic role for Endothelin 1. Arthritis Rheum 1998; 41: 800—807.

Charakida M. , Halcox JP , Sangle S. et al. Preclinical atherosclerotic phenotype in patients with primary antiphospholipid syndrome. Arthritis Rheum 2006; 54: S557 (1345).

Li JJ , Li YS , Zhang Y. , Gao Z. , Li Z. , Qian HY Inflammation a possible pathogenic link to cardiac syndrome X. Med Hypotheses 2006; 66: 87—91.

Kaski JC , Aldama G. , Cosin-Sales J. Cardiac syndrome x. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004; 4: 179—194.

Kattwinkel N. , Villanueva AG , Labib SB et al. Myocardial infarction caused by microvasculopathy in a patient with primary antiphospholipid syndrome . Ann Intern Med 1992; 116: 974—976.

Bugiardini R. , Bairey Merz CN Angina with `normal' coronary arteries: a changing philosophy. JAMA 2005; 26: 477—484.